Locations:
Search
Observational evidence of neuroprotection with GLP-1 receptor agonists and SGLT-2 inhibitors
Tasked-based therapy improves social connection and quality of life
Paired blood and brain tissue methylation findings raise prospect of noninvasive precision diagnosis
Mixed results from phase 2 CALLIPER trial of novel dual-action compound
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers explore how changes in the gut microbiome influence the brain's reward response to alcohol
A co-author of the new recommendations shares the updates you need to know
Success for these complex operations requires judicious patient selection and presurgical patient optimization
Rebound risk is shaped by patient characteristics and mechanism of action of current DMT
First-of-kind prediction model demonstrates high consistency across internal and external validation
Real-world study also finds no significant rise in ocrelizumab-related risk with advanced age
Advertisement
Advertisement